YU80003A - Upotreba proteina uk114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka - Google Patents

Upotreba proteina uk114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka

Info

Publication number
YU80003A
YU80003A YU80003A YUP80003A YU80003A YU 80003 A YU80003 A YU 80003A YU 80003 A YU80003 A YU 80003A YU P80003 A YUP80003 A YU P80003A YU 80003 A YU80003 A YU 80003A
Authority
YU
Yugoslavia
Prior art keywords
fragments
protein
prevention
treatment
endotoxic shock
Prior art date
Application number
YU80003A
Other languages
English (en)
Inventor
Alberto Bartorrrelli
Pierferdinando Nicoletti
Alberto Panerai
Original Assignee
Zetesis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis S.P.A. filed Critical Zetesis S.P.A.
Publication of YU80003A publication Critical patent/YU80003A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Upotreba proteina UK114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka.[The use of the UK114 protein or of fragments thereof for the treatment and prevention of the endotoxic shock is described.
YU80003A 2001-04-10 2002-04-09 Upotreba proteina uk114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka YU80003A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000762A ITMI20010762A1 (it) 2001-04-10 2001-04-10 Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico

Publications (1)

Publication Number Publication Date
YU80003A true YU80003A (sh) 2006-05-25

Family

ID=11447468

Family Applications (1)

Application Number Title Priority Date Filing Date
YU80003A YU80003A (sh) 2001-04-10 2002-04-09 Upotreba proteina uk114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka

Country Status (22)

Country Link
US (1) US20040180835A1 (sh)
EP (1) EP1377308A1 (sh)
JP (1) JP2004526762A (sh)
KR (1) KR20040000423A (sh)
CN (1) CN1501807A (sh)
BG (1) BG108246A (sh)
BR (1) BR0208793A (sh)
CA (1) CA2443726A1 (sh)
CZ (1) CZ20032744A3 (sh)
EE (1) EE200300489A (sh)
HR (1) HRP20030815A2 (sh)
HU (1) HUP0303798A3 (sh)
IL (1) IL158333A0 (sh)
IT (1) ITMI20010762A1 (sh)
MX (1) MXPA03009228A (sh)
NO (1) NO20034723D0 (sh)
PL (1) PL367764A1 (sh)
RU (1) RU2003130226A (sh)
SK (1) SK12582003A3 (sh)
WO (1) WO2002083161A1 (sh)
YU (1) YU80003A (sh)
ZA (1) ZA200307901B (sh)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
CN1151838C (zh) * 1996-09-18 2004-06-02 泽特希斯有限公司 作为抗自身免疫疾病试剂的蛋白的用途
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche

Also Published As

Publication number Publication date
ZA200307901B (en) 2004-10-11
HUP0303798A3 (en) 2005-12-28
HRP20030815A2 (en) 2005-08-31
ITMI20010762A0 (it) 2001-04-10
WO2002083161A1 (en) 2002-10-24
CN1501807A (zh) 2004-06-02
EP1377308A1 (en) 2004-01-07
BR0208793A (pt) 2004-03-09
JP2004526762A (ja) 2004-09-02
MXPA03009228A (es) 2004-03-16
SK12582003A3 (sk) 2004-03-02
CA2443726A1 (en) 2002-10-24
ITMI20010762A1 (it) 2002-10-10
HUP0303798A2 (hu) 2004-03-01
IL158333A0 (en) 2004-05-12
EE200300489A (et) 2003-12-15
BG108246A (bg) 2005-04-30
CZ20032744A3 (en) 2004-05-12
NO20034723L (no) 2003-10-22
RU2003130226A (ru) 2005-02-10
PL367764A1 (en) 2005-03-07
US20040180835A1 (en) 2004-09-16
KR20040000423A (ko) 2004-01-03
NO20034723D0 (no) 2003-10-22

Similar Documents

Publication Publication Date Title
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
MXPA03010327A (es) USO DE OSTEOPONTINA PARA TRATAMIENTO Y/O PREVENCIoN DE ENFERMEDADES NEUROLoGICAS.
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
IL161501A0 (en) Methods of preventing and treating flavivirus infection in animals
WO2004091436A3 (en) Methods and compositions for treating ocular disease
MXPA03006776A (es) Uso de inhibidores de interleucina-18 para el tratamiento y/o prevencion de enfermedad cardiaca.
WO2003013440A3 (en) Treatment and prevention of heat shock protein-associated diseases and conditions
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
GB9916729D0 (en) Fuller for the treatment of leather,pelts and the like
YU80003A (sh) Upotreba proteina uk114 ili njegovih fragmenata za tretman i prevenciju endotoksičnog šoka
WO2003096877A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
HK1062806A1 (en) Novel methods for the treatment and prevention of pain using stress- activated protein kinase inhibitors
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
IL158967A0 (en) Identifying parasitic fungi of the organism, and treatment thereof
SI1392292T1 (sl) Piranoindazoli in njihova uporaba pri zdravljenjuglavkoma
AU2002242488A1 (en) Agents for the prevention and treatment of sexually transmitted diseases -ii
AU2002313005B2 (en) Use of glycoprotein for the treatment and re-epithelisation of wounds
AU2002344855A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
EP1383563A4 (en) METHOD FOR THE TREATMENT OF HIV AND OTHER VIRUSES